Your browser doesn't support javascript.
loading
LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways.
Mosca, Nicola; Khoubai, Fatma Zohra; Fedou, Sandrine; Carrillo-Reixach, Juan; Caruso, Stefano; Del Rio-Alvarez, Alvaro; Dubois, Emeric; Avignon, Christophe; Dugot-Senant, Nathalie; Guettier, Catherine; Mussini, Charlotte; Zucman-Rossi, Jessica; Armengol, Carolina; Thiébaud, Pierre; Veschambre, Philippe; Grosset, Christophe François.
Afiliación
  • Mosca N; MIRCADE Team, Univ. Bordeaux, Inserm, BMGIC, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, U1035, Bordeaux, France.
  • Khoubai FZ; MIRCADE Team, Univ. Bordeaux, Inserm, BMGIC, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, U1035, Bordeaux, France.
  • Fedou S; MIRCADE Team, Univ. Bordeaux, Inserm, BMGIC, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, U1035, Bordeaux, France.
  • Carrillo-Reixach J; XenoFish, Univ. Bordeaux, Inserm, BMGIC, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, U1035, Bordeaux, France.
  • Caruso S; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Del Rio-Alvarez A; CIBER, Hepatic and Digestive Diseases, Barcelona, Spain.
  • Dubois E; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Functional Genomics of Solid Tumors Laboratory, Paris, France.
  • Avignon C; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
  • Dugot-Senant N; Montpellier GenomiX, University of Montpellier, CNRS, INSERM, Montpellier, France.
  • Guettier C; Department of Pathology, Bicêtre University Hospital, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Mussini C; Plateforme d'histopathologie Inserm, US 005 - UMS3427 - TBMCore, Bordeaux, France.
  • Zucman-Rossi J; Department of Pathology, Bicêtre University Hospital, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Armengol C; Department of Pathology, Bicêtre University Hospital, University of Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Thiébaud P; Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Functional Genomics of Solid Tumors Laboratory, Paris, France.
  • Veschambre P; Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Grosset CF; Childhood Liver Oncology Group, Germans Trias i Pujol Research Institute (IGTP), Program for Predictive and Personalized Medicine of Cancer (PMPPC), Badalona, Spain.
Liver Cancer ; 11(2): 126-140, 2022 Apr.
Article en En | MEDLINE | ID: mdl-35634422
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2022 Tipo del documento: Article